Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Spironolactone 2% / Tretinoin 0.025%

Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Spironolactone 2% / Tretinoin 0.025%

BENZOYL PEROXIDE 5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / SPIRONOLACTONE 2% / TRETINOIN 0.025%- benzoyl peroxide 5% / clindamycin 1% / niacinamide 2% / spironolactone 2% / tretinoin 0.025% gel Sincerus Florida, LLC Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here. ---------- BENZOYL PEROXIDE 5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / SPIRONOLACTONE 2% / TRETINOIN 0.025% Directions for use Sincerus Florida, Adverse reactions Active, inactive NDC 72934-1015-2. BENZOYL PEROXIDE USP 5%, CLINDAMYCIN PHOSPHATE USP 1%, NIACINAMIDE USP 4% / SPIRONOLACTONE USP 2% / TRETINOIN USP 0.025%. Gel30gm. BENZOYL PEROXIDE 5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / SPIRONOLACTONE 2% / TRETINOIN 0.025% benzoyl peroxide 5% / clindamycin 1% / niacinamide 2% / spironolactone 2% / tretinoin 0.025% gel Product Information Product T ype HUMAN PRESCRIPTION DRUG Ite m Code (Source ) NDC:729 34-10 15 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength BENZO YL PERO XIDE (UNII: W9 WZN9 A0 GM) (BENZOYL PEROXIDE - BENZOYL PEROXIDE 5 g in 10 0 g UNII:W9 WZN9 A0 GM) CLINDAMYCIN CLINDAMYCIN PHO SPHATE (UNII: EH6 D7113I8 ) (CLINDAMYCIN - UNII:3U0 2EL437C) 1 g in 10 0 g PHOSPHATE 0 .0 25 g TRETINO IN (UNII: 56 8 8 UTC0 1R) (TRETINOIN - UNII:56 8 8 UTC0 1R) TRETINOIN in 10 0 g NIACINAMIDE (UNII: 25X51I8 RD4) (NIACINAMIDE - UNII:25X51I8 RD4) NIACINAMIDE 2 g in 10 0 g SPIRO NO LACTO NE (UNII: 27O7W4T232) (SPIRONOLACTONE - UNII:27O7W4T232) SPIRONOLACTONE 2 g in 10 0 g Product Characteristics Color yello w Score Shape Siz e Flavor Imprint Code Contains Packaging Marketing Start # Item Code Package Description Marketing End Date Date NDC:729 34-10 15- 30 g in 1 BOTTLE, PUMP; Type 0 : No t a Co mbinatio n 1 0 5/0 4/20 19 2 Pro duct Marketing Information Marke ting Cate gory Application Numbe r or Monograph Citation Marke ting Start Date Marke ting End Date unappro ved drug o ther 0 5/0 4/20 19 Labeler - Sincerus Florida, LLC (080105003) Establishment Name Addre ss ID/FEI Busine ss Ope rations Sincerus Flo rida, LLC 0 8 0 10 50 0 3 manufacture(729 34-10 15) Revised: 5/2019 Sincerus Florida, LLC.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    8 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us